Zobrazeno 1 - 10
of 139
pro vyhledávání: '"K, Jesudasan"'
Publikováno v:
Leprosy Review. 74:141-147
The World Health Organization (WHO) Field Trials of multidrug therapy (MDT) started at Schieffelin Leprosy Research and Training Centre (SLR & IC), Karigiri, India in December 1981. The patients were treated with two MDT regimens. The first (regimen
Publikováno v:
Leprosy review. 74(2)
The World Health Organization (WHO) Field Trials of multidrug therapy (MDT) started at Schieffelin Leprosy Research and Training Centre (SLRIC), Karigiri, India in December 1981. The patients were treated with two MDT regimens. The first (regimen A)
Publikováno v:
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 68(4)
Forty-six, newly detected, previously untreated multibacillary (MB) patients with a bacterial index (BI) ofor = 3+ who had received WHO/MDT for 2 years were followed up for a total duration of 424 person-years and a mean duration of 9.26 +/- 2.98 yea
Publikováno v:
Leprosy Review. 70
A study was done on 794 new cases of leprosy among children (aged 0-14 years) detected and treated with MDT during 1990-1995 in Gudiyatham Taluk, South India. Incidence rates of leprosy and proportion of multibacillary cases increased with age, while
Publikováno v:
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 66(2)
The multidrug therapy program with the World Health Organization (WHO)-recommended treatment (WHO/MDT) regimens has given the hope of early case detection and rendering a leprosy patient, especially a multibacillary (MB) patient, noninfectious within
Publikováno v:
Leprosy review. 68(4)
A case of borderline-lepromatous leprosy exhibiting alopecia of the scalp along with lepromatous lymphadenitis of suboccipital lymphnode is reported. To our knowledge generalized leprous alopecia of the scalp with lepromatous lymphadenitis of the sub
Publikováno v:
Leprosy review. 68(2)
Publikováno v:
Leprosy review. 68(1)
New antimycobacterial agents and combined treatment regimens are being introduced for the treatment of leprosy. Ofloxacin is one such broad spectrum antimicrobial agent. In this study rifampicin plus ofloxacin were administered daily for 4 weeks (dai
Publikováno v:
Leprosy Review. 68
An old borderline-lepromatous leprosy patient, treated initially with DDS monotherapy followed by MDT, 11 years later during surveillance presented with 3-month-old asymptomatic cystic swelling, arising from the right ulnar nerve without exhibiting a
Publikováno v:
Indian journal of leprosy. 68(3)
A leprosy survey carried out in a district prison revealed a gross prevalence of 20 cases per 1000, and active prevalence of 10 cases per 1000 whereas, prevalence of leprosy in the state was 1.12 per 1000. Such prisons thus form hyperendemic pockets.